Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 26 , ISSUE 4 ( April, 2022 ) > List of Articles


Outcomes of HFNC Use in COVID-19 Patients in Non-ICU Settings: A Single-center Experience

Anivita Aggarwal, Umang Arora, Ankit Mittal, Arunima Aggarwal, Komal Singh, Pankaj Jorwal, Akhil K Singh

Keywords : COVID-19 ARDS, High-flow Nasal Cannula (HFNC) oxygen therapy, Outside-ICU

Citation Information : Aggarwal A, Arora U, Mittal A, Aggarwal A, Singh K, Jorwal P, Singh AK. Outcomes of HFNC Use in COVID-19 Patients in Non-ICU Settings: A Single-center Experience. Indian J Crit Care Med 2022; 26 (4):530-532.

DOI: 10.5005/jp-journals-10071-24186

License: CC BY-NC 4.0

Published Online: 13-05-2022

Copyright Statement:  Copyright © 2022; The Author(s).


  1. Ray A, Jain D, Goel A, Agarwal S, Swaroop S, Das P, et al. Clinico-pathological features in fatal COVID-19 infection: a preliminary experience of a tertiary care center in North India using postmortem minimally invasive tissue sampling. Expert Rev Respir Med 2021;15(10):1367–1375. DOI: 10.1080/17476348.2021.1951708.
  2. Raoof S, Nava S, Carpati C, Hill NS. High-flow, noninvasive ventilation and awake (nonintubation) proning in patients with coronavirus disease 2019 with respiratory failure. Chest 2020;158(5):1992–2002. DOI: 10.1016/j.chest.2020.07.013.
  3. Kodama T, Obinata H, Mori H, Murakami W, Suyama Y, Sasaki H, et al. Prediction of an increase in oxygen requirement of SARS-CoV-2 pneumonia using three different scoring systems. J Infect Chemother 2021;27(2):336–341. DOI: 10.1016/j.jiac.2020.12.009.
  4. Calligaro GL, Lalla U, Audley G, Gina P, Miller MG, Mendelson M, et al. The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: a multi-centre prospective observational study. EClinicalMedicine 2020;28. Available from:
  5. Lu X, Jiang L, Chen T, Wang Y, Zhang B, Hong Y, et al. Continuously available ratio of SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19. Respir Res 2020;21(1):194. DOI: 10.1186/s12931-020-01455-4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.